Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

    brain
    Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. News & Events
  3. Events
  4. Webinars
  5. Decentralised Clinical Trials: An Introduction and Operational Best Practices

Decentralised Clinical Trials: An Introduction and Operational Best Practices

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

  • Date 20 September 2023
    Time 09:00 - 15:00
    Location Webinar
    Timezone Asia/Seoul

Overview

In this webinar, ICON will provide insights on the Decentralised Clinical Trial (DCT) landscape, including definitions, regulatory framework, elements of decentralization and operational best practices. This webinar will seek to address many questions around what DCT is and best practices for implementing this in the drug development pathway.

Time

Subject name

Objectives

Targeting contents 

Speaker

09:00~10:00 DCT Element -DHT Defining what is a DCT versus a hybrid Types of clinical trials Kimberly Dley
10:00~11:00 DCT Element – Community Research Looking at best approach to community research Community Research Darlene Ellenor
11:00~12:00 DCT Element – DHT Looking at Digital Health Technologies Digital Health Technology Keith Thomas

12:00~13:00

DCT Element – Digital Platforms Best practices for evaluating digital platforms Digital Platforms Alex Crawford
13:00~14:00

Lunch

14:00~15:00 DCT – Bringing it all together Operationally review and deploying fit for purpose DCT elements Operationalization Cristobal Castillo

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Registration details

Cost: 37,500 KRW

Watch the webinar

Speakers

Emily Mitchell

Executive Director, Decentralised Clinical Trials Operations, ICON plc

Emily Mitchell has over 15 years of experience in the CRO industry, working across multiple functions including Data Management, Project Management and Clinical Operations. During her time at ICON, Emily partnered with Actigraph to run a pilot study with employees on the wear compliance and comparison of a medical grade activity tracker to commercial grade devices. Just prior to the pandemic, Emily managed the set-up and support of the first fully decentralised clinical trial to have published positive results in a peer reviewed publication, Nature. 

Emily has presented on the best practices in decentralising studies, ensuring patient and site burden is minimised while optimising data capture, at numerous industry forums and conferences. She is an active member of SCDM and continues to support the progression of the industry in this innovative space.

Kimberly Dley

Business Operations Manager, Decentralized Clinical Trials Operations

Kimberly has 10 years of CRO experience, spanning across biometrics, project management and business operations roles.

Kimberly oversees the implementation of DCT strategy and solutions for hybrid in-flight trials and has been a project manager during the start-up of a full DCT. She also provides consultative guidance to embed DCT elements to add value to trials. Finally, Kim is an active contributor in developing and change management of operational processes to set trials teams up for success in deploying DCT strategies.

She holds a Master of Business Administration specialized in Digital Transformation, a Bachelor of Science degree in Biology, and is a certified Project Management Professional.

Darlene Ellenor

Director of Project Operations, Decentralized Clinical Trials Operations

Darlene has been working in the Clinical Trials industry for over 14 years, including 10 years in Project Management and 1.5 years in the Decentralized Clinical Trials Operations department.

Darlene oversees the Project Management team working on fully decentralized clinical trials at ICON. She has worked on 3 fully decentralized studies as a Director of Project Delivery. She also leads the team creating/modifying tools and templates for Project Managers to lead decentralized clinical trials.

She holds a Master of Science degree in Medical Genetics and is a certified Project Management Professional.
 

Keith Thomas

Senior Director, Decentralised Clinical Trials Solutions

Keith directs the strategic planning and operational use of digital health technologies, digital biomarkers, and digital endpoints for clinical trials at ICON. His background gives him unique insight into both the technical aspects underlying digital health technologies, as well as first-hand experience with real world usage. He leverages this experience to devise successful strategies for clients.  

Prior to joining ICON, Keith held product and program management roles, driving the successful integration, deployment, and utilisation of digital health technologies in remote patient monitoring, virtual care and clinical research applications. Earlier in his career he held positions at medical device and digital health organisations, focusing on the design and development of hardware, firmware, and software for a variety of digital health technologies.

Keith holds a Bachelor of Science degree in Computer Engineering.

Alex Crawford

DCT Product Director, Decentralized Clinical Trials Operations

Alex Crawford has 15 years of experience working with clinical technology spanning across multiple Decentralized, Data Management, and Clinical Operations applications. During his time at ICON, Alex has worked to expand partnerships with existing DCT vendors and has played an important role in the growth of ICON’s home grown technology suite.

Alex has presented on DCT technology methodologies for SCDM and has spoken at numerous conferences around eSource and DCT technology selection.
 

Cristobal Castillo

Director of Project Operations, Decentralized Clinical Trials Operations

Cristobal has over 23 years in clinical research staring as a CRA and moving up to Director. He has mainly worked in Oncology. Cristobal has recently moved to the Decentralized Operations department.

Cristobal works with the business department in proposals for our potential clients, analyzing the potential of each protocol for decentralization and proposing strategy and budget. He is also involved in several internal initiatives to develop and improve our processes in a ever changing environment.

Cristobal has a Pharmacy Degree and a Master in Clinical Trials and Project Management. He is based in Spain.
 

In this section
In this section
  • Press releases
  • In the News
  • Mediakit
    • Facts and figures
    • ICON spokespeople
  • Awards
  • Events
    • Industry events
    • Webinars
    • Workshops
  • Webinars
  • Social media

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence